Cystine, Random Urine with Creatinine

For Specimen Integrity during Extreme Weather see the “Lockbox Usage in Extreme Weather” document at the top of this page.

Test Code

CPT Codes
86160, 82131, 82570


Preferred Specimen
1.8 mL unpreserved random urine collected in a sterile screw-cap container

Minimum Volume
0.6 mL

Other Acceptable Specimens
Unpreserved Catheterized urine or First void clean-catch urine, or random clean-catch urine collected in a sterile screw-cap container

Do not use preservatives. Do not thaw. Urine with a pH less than 2.0 will be rejected.

Patient age is required for correct reference range.

Transport Temperature

Specimen Stability
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 60 days

Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Received room temperature • Received refrigerated • pH <2.0

Liquid Chromatography/Mass Spectrometry (LC/MS)

FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Setup Schedule
Set up: Tues, Thurs; Report available: 4-9 days

Reference Range
Pediatric (<18 Years) 3.2-12.6 mmol/mol creat
Adult 3.4-16.4 mmol/mol creat

Creatinine, Random Urine
0-6 Months 0.18-2.48 mmol/L
7-11 Months   0.18-2.74 mmol/L
1-2 Years 0.18-9.72 mmol/L
3-8 Years 0.18-11.49 mmol/L
9-12 Years 0.18-14.14 mmol/L
>12 Years 1.77-23.31 mmol/L

Clinical Significance

This quantitative test may be useful for evaluation of individuals with clinically suspected cystinuria, including those with symptoms of kidney stones or cystine crystals detected in urinalysis [1]. Although 24-hour urine testing is generally preferred for diagnostic evaluation and monitoring of cystinuria [2], random or first-morning void urine collection may be helpful for diagnosis when 24-hour urine collection is not feasible (eg, for young children) [3].

Cystinuria, an autosomal recessive genetic disorder that can cause kidney stones, is characterized by excessive excretion of cystine and dibasic amino acids in the urine. Around 1% to 2% of all kidney stones, and 6% to 8% of kidney stones in children, are caused by cystinuria [1]. Approximately 83% of patients with cystinuria who develop a kidney stone will have a recurrence within 5 years [1]. Common complications of cystinuria include chronic kidney disease and hypertension [1].

This test does not differentiate between free and bound cystine in patients taking cystine-binding thiol drugs [1]. This test alone is not sufficient to predict risk of kidney stones in individuals with cystinuria [1].

The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.

1. Daga S, et al. Urology. 2021;149:70-75.
2. Williams JC Jr, et al. Urolithiasis. 2021;49(1):1-16.
3. Servais A, et al. Kidney Int. 2021;99(1):48-58.

Performing Laboratory
Quest Diagnostics Nichols Institute-San Juan Capistrano, CA
33608 Ortega Highway
San Juan Capistrano, CA 92675-2042

Last Updated: November 29, 2021

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.